Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

54.050
-2.000-3.57%
Volume:8.10M
Turnover:440.11M
Market Cap:222.47B
PE:39.79
High:55.850
Open:55.050
Low:53.850
Close:56.050
52wk High:56.500
52wk Low:28.480
Shares:4.12B
HK Float Shares:4.12B
Volume Ratio:0.71
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.358
ROE:11.38%
ROA:7.60%
PB:3.95
PE(LYR):39.79
PS:8.05

Loading ...

Movement Alert|WUXI BIO Rises 4.75% in Regular Trading, CXO Sector Momentum Continues Amid Acquisition and Earnings Catalysts

Market Focus
·
Aug 10

Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust

Stock News
·
Aug 07

Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts

Stock News
·
Aug 07

WuXi Bio Co., Ltd. gains nearly 6% in early trading, plans to acquire ChuangSheng Pharma's process development and manufacturing base in Hangzhou

Deep News
·
Aug 07

Movement Alert|WUXI BIO Rises 3.19% in Regular Trading, CXO Sector Rallies on Strong Peer Earnings and Upcoming Interim Results

Market Focus
·
Aug 07

Transcenta Agrees to Sell CDMO Assets to WuXi Biologics Unit for RMB 190 Million

Reuters
·
Aug 07

Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million

Reuters
·
Aug 06

Wuxi Biologics (Cayman) Stock Advances 1.9% in Hong Kong

Dow Jones
·
Aug 06

Movement Alert|WUXI BIO Rises 3.1% in Regular Trading, CXO Sector Strength and Interim Earnings Expectations Serve as Catalysts

Market Focus
·
Aug 06

Wuxi Biologics (Cayman) Stock Climbs 4.3% in Hong Kong

Dow Jones
·
Aug 04

CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance

Stock News
·
Aug 04

Hong Kong Market Opens Higher as Pharma and Tech Stocks Lead Gains

Stock News
·
Aug 04

Movement Alert|WUXI BIO Rises 4.85% in Regular Trading, CXO Sector Broad Rally Lifts Life Sciences Stocks

Market Focus
·
Aug 04

Wuxi Biologics (Cayman) Stock Rallies 2.5% in Hong Kong

Dow Jones
·
Jul 31

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

Movement Alert|WUXI BIO Rises 3.07% in Regular Trading, CXO Sector Rallies on Accelerating Industry Recovery

Market Focus
·
Jul 31

Wuxi Biologics (Cayman) Stock Slips 4.0% in Hong Kong

Dow Jones
·
Jul 30

Movement Alert|WUXI BIO Falls 3.15% in Regular Trading, Life Sciences Sector Broadly Weakens as Subsidiary Faces Target Price Cut

Market Focus
·
Jul 30

WuXi Biologics Added to FTSE4Good Index Series for Sixth Straight Year

Reuters
·
Jul 29

Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$51.38 From HK$50.54, Keeps at Buy

MT Newswires Live
·
Jul 27